186 related articles for article (PubMed ID: 36315461)
1. Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review.
Guillaume D; Meyer D; Waheed DE; Schlieff M; Muralidharan K; Chou VB; Limaye R
Health Policy Plan; 2023 Mar; 38(3):363-376. PubMed ID: 36315461
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Donadel M; Panero MS; Ametewee L; Shefer AM
Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
6. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
7. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
[TBL] [Abstract][Full Text] [Related]
8. The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.
Hutubessy R; Lauer JA; Giersing B; Sim SY; Jit M; Kaslow D; Botwright S
BMC Med; 2023 Jul; 21(1):229. PubMed ID: 37400797
[TBL] [Abstract][Full Text] [Related]
9. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
[TBL] [Abstract][Full Text] [Related]
10. Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives.
Guillaume D; Waheed DE; Schlieff M; Muralidharan K; Vorsters A; Limaye R
Hum Vaccin Immunother; 2022 Dec; 18(7):2150454. PubMed ID: 36485172
[TBL] [Abstract][Full Text] [Related]
11. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
12. Health actor approaches to financing universal coverage strategies for pneumococcal and rotavirus immunisation programmes in low-income and middle-income countries: a scoping review protocol.
Ogundele OJ; Fadel S; Braitstein P; Di Ruggiero E
BMJ Open; 2021 Dec; 11(12):e052381. PubMed ID: 34907060
[TBL] [Abstract][Full Text] [Related]
13. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.
Loganathan T; Ng CW; Lee WS; Hutubessy RCW; Verguet S; Jit M
Health Policy Plan; 2018 Mar; 33(2):204-214. PubMed ID: 29228339
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.
Ortiz JR; Neuzil KM
Expert Rev Vaccines; 2019 Jul; 18(7):711-724. PubMed ID: 31226895
[No Abstract] [Full Text] [Related]
15. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
Hendriks J; Hutubessy RCW; Grohmann G; Torelli G; Friede M; Kieny MP
Vaccine; 2018 Jun; 36(28):3993-3997. PubMed ID: 29866617
[TBL] [Abstract][Full Text] [Related]
16. Evidence of the factors that influence the utilisation of Kangaroo Mother Care by parents with low-birth-weight infants in low- and middle-income countries (LMICs): a scoping review protocol.
Mathias CT; Mianda S; Ginindza TG
Syst Rev; 2018 Apr; 7(1):55. PubMed ID: 29622026
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of frameworks for the interrelationships of mental health evidence and policy in low- and middle-income countries.
Votruba N; Ziemann A; Grant J; Thornicroft G
Health Res Policy Syst; 2018 Aug; 16(1):85. PubMed ID: 30134908
[TBL] [Abstract][Full Text] [Related]
18. Implementation of colorectal cancer screening interventions in low-income and middle-income countries: a scoping review protocol.
Schliemann D; Matovu N; Ramanathan K; Muñoz-Aguirre P; O'Neill C; Kee F; Su TT; Donnelly M
BMJ Open; 2020 Jun; 10(6):e037520. PubMed ID: 32532782
[TBL] [Abstract][Full Text] [Related]
19. The impact of new vaccine introduction on immunization and health systems: a review of the published literature.
Hyde TB; Dentz H; Wang SA; Burchett HE; Mounier-Jack S; Mantel CF;
Vaccine; 2012 Oct; 30(45):6347-58. PubMed ID: 22940378
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
